Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

JPM 2022: Abiomed, Penumbra, Renalityx

Jan 14 2022

• By Reed Miller

J.P. Morgan Daily Notebook 2022 Day 4 — • Source: Alamy

Related Content

Renalytix Collaborates With ADA To Improve Early Detection Of Kidney Disease

Jan 10 2022

Cardiovascular Catch-Up: Abbott, Medtronic, Boston Scientific Stay Hot During Summer

Sep 07 2021

Abiomed Manages Pandemic Recovery By Moving Operations Online

Aug 10 2020

Renalytix AI And AstraZeneca Collaborate To Improve Chronic Kidney Disease Outcomes

Aug 24 2020

Related Companies

Abiomed, Inc.

preCARDIA, Inc.

Additional Topics

Reimbursement Clinical Trials Sales & Earnings Business Strategies Approvals Commercial Companies Digital Health M & A Diabetic Care Cardiovascular Medical Device

More from Policy & Regulation

More from Medtech Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.